Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Shore, Neal D"'
Autor:
Gomez-Veiga F; Complexo Hospitalario Universitario de A Coruña, Coruña, Spain. Electronic address: fgveiga@telefonica.net., Szmulewitz RZ; The University of Chicago, Chicago, IL, USA., Holzbeierlein J; The University of Kansas Medical Center, Kansas City, KS, USA., Azad AA; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Iguchi T; Kanazawa Medical University, Ishikawa, Japan., Villers A; University Hospital Centre, Lille University, Lille, France., Alcaraz A; Hospital Clinic de Barcelona, Barcelona, Spain., Alekseev B; Hertzen Moscow Cancer Research Institute, Moscow, Russia., Shore ND; Carolina Urologic Research Center, Myrtle Beach, SC, USA., Rosbrook B; Pfizer Inc., San Diego, CA, USA., Zohren F; Pfizer Inc., San Diego, CA, USA., Ma J; Astellas Pharma Inc., Northbrook, IL, USA., Haas GP; Astellas Pharma Inc., Northbrook, IL, USA., Stenzl A; University Hospital, Eberhard Karls University of Tübingen, Tübingen, Germany., Armstrong AJ; Duke Cancer Institute Center for Prostate & Urologic Cancers, Duke University, Durham, NC, USA.
Publikováno v:
European urology oncology [Eur Urol Oncol] 2024 Aug; Vol. 7 (4), pp. 860-869. Date of Electronic Publication: 2023 Dec 09.
Autor:
Yu EY; Division of Hematology and Oncology, Fred Hutchinson Cancer Center and University of Washington, Seattle, WA, USA. Electronic address: evanyu@u.washington.edu., Berry WR; Duke Cancer Center Cary, Cary, NC, USA., Gurney H; Department of Clinical Medicine, Macquarie University, Sydney, Australia., Retz M; University Hospital Rechts der Isar, Technical University of Munich, Munich, Germany., Conter HJ; University of Western Ontario, Brampton, Canada., Laguerre B; Center Eugène Marquis, Rennes, France., Fong PCC; Aukland City Hospital and the University of Aukland., Ferrario C; Jewish General Hospital, Montreal, Canada., Todenhöfer T; Studienpraxis Urologie, Nürtingen, Germany., Gravis G; Institut Paoli-Calmettes, Marseille, France., Piulats JM; Catalan Institute of Oncology, Barcelona, Spain., Emmenegger U; Division of Medical Oncology, Odette Cancer Centre, Toronto, Canada., Shore ND; Carolina Urologic Research Center, Myrtle Beach, SC, USA., Romano E; Department of Oncology, Center for Cancer Immunotherapy, Institut Curie, Paris, France., Mourey L; Department of Medical Oncology, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France., Li XT; MSD China, Beijing, China., Poehlein CH; Merck & Co., Inc., Rahway, NJ, USA., Schloss C; Merck & Co., Inc., Rahway, NJ, USA., Appleman LJ; UPMC Hillman Cancer Center, Pittsburgh, PA, USA., de Bono JS; The Institute of Cancer Research, The Royal Marsden Hospital, London, UK.
Publikováno v:
European urology oncology [Eur Urol Oncol] 2024 Jun; Vol. 7 (3), pp. 509-518. Date of Electronic Publication: 2023 Nov 07.
Autor:
Ross AE; Urology, Northwestern University Feinberg School of Medicine, Chicago, IL., Iwata KK; Medical Affairs, Astellas Pharma Inc, Northbrook, IL., Elsouda D; Data Science, Astellas Pharma Inc, Northbrook, IL., Hairston J; Oncology, Astellas Pharma Inc, Northbrook, IL., Russell D; Medical Affairs, Pfizer Inc, New York, NY., Davicioni E; Urology, Veracyte, Inc, San Francisco, CA., Proudfoot JA; Urology, Veracyte, Inc, San Francisco, CA., Shore ND; Urology, Carolina Urologic Research Center, Myrtle Beach, SC., Schaeffer EM; Urology, Northwestern University Feinberg School of Medicine, Chicago, IL.
Publikováno v:
JCO precision oncology [JCO Precis Oncol] 2024 Apr; Vol. 8, pp. e2300603.
Autor:
Agarwal N; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT 84112, USA., Saad F; University of Montréal Hospital Center, Montréal, Québec, H2L 4M1, Canada., Azad AA; Peter MacCallum Cancer Centre, Melbourne, Victoria, 3000, Australia., Mateo J; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, 08035, Barcelona, Spain., Matsubara N; National Cancer Center Hospital East, Chiba, 277-8577, Japan., Shore ND; Carolina Urologic Research Center, Myrtle Beach, SC 29572, USA., Chakrabarti J; Pfizer Ltd., Tadworth, Surrey, KT20 7NS, UK., Chen HC; Pfizer Inc., La Jolla, CA 92121, USA., Lanzalone S; Pfizer Oncology, Milan, 20152, Italy., Niyazov A; Pfizer Inc., New York, NY, 10012, USA., Fizazi K; Institut Gustave Roussy, University of Paris Sud, Villejuif, 94800, France.
Publikováno v:
Future oncology (London, England) [Future Oncol] 2024 Mar; Vol. 20 (9), pp. 493-505. Date of Electronic Publication: 2023 Oct 26.
Autor:
Fizazi K; Institut Gustave Roussy, University of Paris-Saclay, Villejuif, France. karim.fizazi@gustaveroussy.fr., Azad AA; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Matsubara N; National Cancer Center Hospital East, Chiba, Japan., Carles J; Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Fay AP; PUCRS School of Medicine, Porto Alegre, Brazil., De Giorgi U; IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) Dino Amadori, Meldola, Italy., Joung JY; National Cancer Center, Goyang, Republic of Korea., Fong PCC; Auckland City Hospital, Auckland, New Zealand.; University of Auckland, Auckland, New Zealand., Voog E; Clinique Victor Hugo Centre Jean Bernard, Le Mans, France., Jones RJ; School of Cancer Sciences, University of Glasgow, Beatson West of Scotland Cancer Centre, Glasgow, UK., Shore ND; Carolina Urologic Research Center, Myrtle Beach, SC, USA., Dunshee C; Arizona Urology Specialists, Tucson, AZ, USA., Zschäbitz S; National Center for Tumor Diseases (NCT), Heidelberg University Hospital, Heidelberg, Germany., Oldenburg J; Akershus University Hospital (Ahus), Lørenskog, Norway., Ye D; Fudan University Shanghai Cancer Center, Shanghai, China., Lin X; Pfizer Inc., La Jolla, CA, USA., Healy CG; Pfizer Inc., Collegeville, PA, USA., Di Santo N; Pfizer Inc., Durham, NC, USA., Laird AD; Pfizer Inc., La Jolla, CA, USA., Zohren F; Pfizer Inc., New York, NY, USA., Agarwal N; Huntsman Cancer Institute (NCI-CCC), University of Utah, Salt Lake City, UT, USA. neeraj.agarwal@hci.utah.edu.
Publikováno v:
Nature medicine [Nat Med] 2024 Jan; Vol. 30 (1), pp. 257-264. Date of Electronic Publication: 2023 Dec 04.
Autor:
Azad AA; Monash Health, Melbourne, VIC, Australia.; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Armstrong AJ; Duke Cancer Institute Center for Prostate & Urologic Cancers, Durham, NC, USA. andrew.armstrong@duke.edu., Alcaraz A; Hospital Clinic de Barcelona, Barcelona, Spain., Szmulewitz RZ; The University of Chicago, Chicago, IL, USA., Petrylak DP; Yale Cancer Center, New Haven, CT, USA., Holzbeierlein J; The University of Kansas Medical Center, Kansas City, KS, USA., Villers A; Lille University, Lille, France., Alekseev B; Hertzen Moscow Cancer Research Institute, Moscow, Russia., Iguchi T; Osaka City University Graduate School of Medicine, Osaka, Japan., Shore ND; Carolina Urologic Research Center, Myrtle Beach, SC, USA., Gomez-Veiga F; University Hospital, GITUR-IBSAL, University of Salamanca, Salamanca, Spain., Rosbrook B; Pfizer Inc., San Diego, CA, USA., Lee HJ; Astellas Pharma Inc., Northbrook, IL, USA., Haas GP; Astellas Pharma Inc., Northbrook, IL, USA., Stenzl A; Eberhard Karls University of Tübingen, Tübingen, Germany.
Publikováno v:
Prostate cancer and prostatic diseases [Prostate Cancer Prostatic Dis] 2022 Feb; Vol. 25 (2), pp. 274-282. Date of Electronic Publication: 2021 Aug 21.
Autor:
Agarwal N; Huntsman Cancer Institute (NCI-CCC), University of Utah, Salt Lake City, UT 84112, USA., Azad A; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, 3000, Australia., Shore ND; Department of Urology, Carolina Urologic Research Center, Myrtle Beach, SC 29572, USA., Carles J; Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona , 08035, Spain., Fay AP; PUCRS School of Medicine Grupo Oncoclínicas, Porto Alegre , 90610-000, Brazil., Dunshee C; Urological Associates of Southern Arizona, Tucson, AZ 85741, USA., Karsh LI; The Urology Center of Colorado, Denver, CO 80211, USA., Paccagnella ML; Pfizer Inc., Global Product Development, Groton, CT 06340, USA., Santo ND; Pfizer Inc., Global Product Development, Durham, NC 27707, USA., Elmeliegy M; Pfizer Inc., Global Product Development, La Jolla, CA 92121, USA., Lin X; Pfizer Inc., Global Product Development, La Jolla, CA 92121, USA., Czibere A; Pfizer Inc., Cambridge, MA, USA., Fizazi K; Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Saclay, Villejuif, 94800, France.
Publikováno v:
Future oncology (London, England) [Future Oncol] 2022 Feb; Vol. 18 (4), pp. 425-436. Date of Electronic Publication: 2022 Jan 26.
Autor:
Armstrong AJ; Duke Cancer Institute Center for Prostate & Urologic Cancers, Durham, North Carolina., Shore ND; Carolina Urologic Research Center, Myrtle Beach, South Carolina., Szmulewitz RZ; The University of Chicago, Chicago, Illinois., Petrylak DP; Yale Cancer Center, New Haven, Connecticut., Holzbeierlein J; The University of Kansas Medical Center, Kansas City, Kansas., Villers A; University Hospital Centre, Lille University, Lille, France., Azad A; Monash Health, Melbourne, Victoria, Australia., Alcaraz A; Hospital Clinic de Barcelona, Barcelona, Spain., Alekseev B; Hertzen Moscow Cancer Research Institute, Moscow, Russia., Iguchi T; Osaka City University Graduate School of Medicine, Osaka, Japan., Gomez-Veiga F; Hospital Universitario de Salamanca, GITUR-IBSAL, Salamanca, Spain., Rosbrook B; Pfizer Inc. , San Diego, California., Lee HJ; Astellas Pharma Inc., Northbrook, Illinois., Haas GP; Astellas Pharma Inc., Northbrook, Illinois., Stenzl A; University Hospital, Eberhard Karls University of Tübingen, Tübingen, Germany.
Publikováno v:
The Journal of urology [J Urol] 2021 May; Vol. 205 (5), pp. 1361-1371. Date of Electronic Publication: 2020 Dec 28.
Autor:
Saad F; University of Montreal Hospital Center (CHUM), Montreal, QC, Canada. Electronic address: fred.saad@umontreal.ca., Sternberg CN; Weill Cornell Medicine, New York, NY, USA., Efstathiou E; MD Anderson Cancer Center, Houston, TX, USA., Fizazi K; University of Paris Saclay, Villejuif, France., Modelska K; Pfizer Inc., San Francisco, CA, USA., Lin X; Pfizer Inc., La Jolla, CA, USA., Sugg J; Astellas Pharma, Inc., Northbrook, IL, USA., Steinberg J; Astellas Pharma, Inc., Northbrook, IL, USA., Noerby B; Sygehus, Lillebælt, Vejle, Denmark., Shore ND; Carolina Urologic Research Center, Myrtle Beach, SC, USA., Hussain M; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA.
Publikováno v:
European urology [Eur Urol] 2020 Dec; Vol. 78 (6), pp. 847-853. Date of Electronic Publication: 2020 Oct 01.
Autor:
Sternberg CN; From the Englander Institute for Precision Medicine, Weill Cornell Medicine, New York (C.N.S.); the University of Paris Saclay, Villejuif, France (K.F.); the University of Montreal Hospital Center, Montreal (F.S.), and Cross Cancer Institute, University of Alberta, Edmonton (M.P.K.) - both in Canada; the Carolina Urologic Research Center, Myrtle Beach, SC (N.D.S.); Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy (U.D.); Vanderbilt University, Nashville (D.F.P.); the State University of Campinas (Unicamp), Campinas (U.F.), and the ABC Foundation School of Medicine, Santo André (D.I.G.C.) - both in Brazil; M.D. Anderson Cancer Center, Houston (E.E.); Wroclaw Medical University, Wroclaw, Poland (K. Madziarska); Sygehus Lillebælt, Vejle, Denmark (B.N.); Pfizer, La Jolla (F.Z., X.L.), and Pfizer, San Francisco (K. Modelska) - both in California; and Astellas Pharma, Northbrook (J. Sugg, J. Steinberg), and the Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago (M.H.) - both in Illinois., Fizazi K; From the Englander Institute for Precision Medicine, Weill Cornell Medicine, New York (C.N.S.); the University of Paris Saclay, Villejuif, France (K.F.); the University of Montreal Hospital Center, Montreal (F.S.), and Cross Cancer Institute, University of Alberta, Edmonton (M.P.K.) - both in Canada; the Carolina Urologic Research Center, Myrtle Beach, SC (N.D.S.); Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy (U.D.); Vanderbilt University, Nashville (D.F.P.); the State University of Campinas (Unicamp), Campinas (U.F.), and the ABC Foundation School of Medicine, Santo André (D.I.G.C.) - both in Brazil; M.D. Anderson Cancer Center, Houston (E.E.); Wroclaw Medical University, Wroclaw, Poland (K. Madziarska); Sygehus Lillebælt, Vejle, Denmark (B.N.); Pfizer, La Jolla (F.Z., X.L.), and Pfizer, San Francisco (K. Modelska) - both in California; and Astellas Pharma, Northbrook (J. Sugg, J. Steinberg), and the Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago (M.H.) - both in Illinois., Saad F; From the Englander Institute for Precision Medicine, Weill Cornell Medicine, New York (C.N.S.); the University of Paris Saclay, Villejuif, France (K.F.); the University of Montreal Hospital Center, Montreal (F.S.), and Cross Cancer Institute, University of Alberta, Edmonton (M.P.K.) - both in Canada; the Carolina Urologic Research Center, Myrtle Beach, SC (N.D.S.); Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy (U.D.); Vanderbilt University, Nashville (D.F.P.); the State University of Campinas (Unicamp), Campinas (U.F.), and the ABC Foundation School of Medicine, Santo André (D.I.G.C.) - both in Brazil; M.D. Anderson Cancer Center, Houston (E.E.); Wroclaw Medical University, Wroclaw, Poland (K. Madziarska); Sygehus Lillebælt, Vejle, Denmark (B.N.); Pfizer, La Jolla (F.Z., X.L.), and Pfizer, San Francisco (K. Modelska) - both in California; and Astellas Pharma, Northbrook (J. Sugg, J. Steinberg), and the Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago (M.H.) - both in Illinois., Shore ND; From the Englander Institute for Precision Medicine, Weill Cornell Medicine, New York (C.N.S.); the University of Paris Saclay, Villejuif, France (K.F.); the University of Montreal Hospital Center, Montreal (F.S.), and Cross Cancer Institute, University of Alberta, Edmonton (M.P.K.) - both in Canada; the Carolina Urologic Research Center, Myrtle Beach, SC (N.D.S.); Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy (U.D.); Vanderbilt University, Nashville (D.F.P.); the State University of Campinas (Unicamp), Campinas (U.F.), and the ABC Foundation School of Medicine, Santo André (D.I.G.C.) - both in Brazil; M.D. Anderson Cancer Center, Houston (E.E.); Wroclaw Medical University, Wroclaw, Poland (K. Madziarska); Sygehus Lillebælt, Vejle, Denmark (B.N.); Pfizer, La Jolla (F.Z., X.L.), and Pfizer, San Francisco (K. Modelska) - both in California; and Astellas Pharma, Northbrook (J. Sugg, J. Steinberg), and the Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago (M.H.) - both in Illinois., De Giorgi U; From the Englander Institute for Precision Medicine, Weill Cornell Medicine, New York (C.N.S.); the University of Paris Saclay, Villejuif, France (K.F.); the University of Montreal Hospital Center, Montreal (F.S.), and Cross Cancer Institute, University of Alberta, Edmonton (M.P.K.) - both in Canada; the Carolina Urologic Research Center, Myrtle Beach, SC (N.D.S.); Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy (U.D.); Vanderbilt University, Nashville (D.F.P.); the State University of Campinas (Unicamp), Campinas (U.F.), and the ABC Foundation School of Medicine, Santo André (D.I.G.C.) - both in Brazil; M.D. Anderson Cancer Center, Houston (E.E.); Wroclaw Medical University, Wroclaw, Poland (K. Madziarska); Sygehus Lillebælt, Vejle, Denmark (B.N.); Pfizer, La Jolla (F.Z., X.L.), and Pfizer, San Francisco (K. Modelska) - both in California; and Astellas Pharma, Northbrook (J. Sugg, J. Steinberg), and the Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago (M.H.) - both in Illinois., Penson DF; From the Englander Institute for Precision Medicine, Weill Cornell Medicine, New York (C.N.S.); the University of Paris Saclay, Villejuif, France (K.F.); the University of Montreal Hospital Center, Montreal (F.S.), and Cross Cancer Institute, University of Alberta, Edmonton (M.P.K.) - both in Canada; the Carolina Urologic Research Center, Myrtle Beach, SC (N.D.S.); Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy (U.D.); Vanderbilt University, Nashville (D.F.P.); the State University of Campinas (Unicamp), Campinas (U.F.), and the ABC Foundation School of Medicine, Santo André (D.I.G.C.) - both in Brazil; M.D. Anderson Cancer Center, Houston (E.E.); Wroclaw Medical University, Wroclaw, Poland (K. Madziarska); Sygehus Lillebælt, Vejle, Denmark (B.N.); Pfizer, La Jolla (F.Z., X.L.), and Pfizer, San Francisco (K. Modelska) - both in California; and Astellas Pharma, Northbrook (J. Sugg, J. Steinberg), and the Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago (M.H.) - both in Illinois., Ferreira U; From the Englander Institute for Precision Medicine, Weill Cornell Medicine, New York (C.N.S.); the University of Paris Saclay, Villejuif, France (K.F.); the University of Montreal Hospital Center, Montreal (F.S.), and Cross Cancer Institute, University of Alberta, Edmonton (M.P.K.) - both in Canada; the Carolina Urologic Research Center, Myrtle Beach, SC (N.D.S.); Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy (U.D.); Vanderbilt University, Nashville (D.F.P.); the State University of Campinas (Unicamp), Campinas (U.F.), and the ABC Foundation School of Medicine, Santo André (D.I.G.C.) - both in Brazil; M.D. Anderson Cancer Center, Houston (E.E.); Wroclaw Medical University, Wroclaw, Poland (K. Madziarska); Sygehus Lillebælt, Vejle, Denmark (B.N.); Pfizer, La Jolla (F.Z., X.L.), and Pfizer, San Francisco (K. Modelska) - both in California; and Astellas Pharma, Northbrook (J. Sugg, J. Steinberg), and the Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago (M.H.) - both in Illinois., Efstathiou E; From the Englander Institute for Precision Medicine, Weill Cornell Medicine, New York (C.N.S.); the University of Paris Saclay, Villejuif, France (K.F.); the University of Montreal Hospital Center, Montreal (F.S.), and Cross Cancer Institute, University of Alberta, Edmonton (M.P.K.) - both in Canada; the Carolina Urologic Research Center, Myrtle Beach, SC (N.D.S.); Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy (U.D.); Vanderbilt University, Nashville (D.F.P.); the State University of Campinas (Unicamp), Campinas (U.F.), and the ABC Foundation School of Medicine, Santo André (D.I.G.C.) - both in Brazil; M.D. Anderson Cancer Center, Houston (E.E.); Wroclaw Medical University, Wroclaw, Poland (K. Madziarska); Sygehus Lillebælt, Vejle, Denmark (B.N.); Pfizer, La Jolla (F.Z., X.L.), and Pfizer, San Francisco (K. Modelska) - both in California; and Astellas Pharma, Northbrook (J. Sugg, J. Steinberg), and the Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago (M.H.) - both in Illinois., Madziarska K; From the Englander Institute for Precision Medicine, Weill Cornell Medicine, New York (C.N.S.); the University of Paris Saclay, Villejuif, France (K.F.); the University of Montreal Hospital Center, Montreal (F.S.), and Cross Cancer Institute, University of Alberta, Edmonton (M.P.K.) - both in Canada; the Carolina Urologic Research Center, Myrtle Beach, SC (N.D.S.); Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy (U.D.); Vanderbilt University, Nashville (D.F.P.); the State University of Campinas (Unicamp), Campinas (U.F.), and the ABC Foundation School of Medicine, Santo André (D.I.G.C.) - both in Brazil; M.D. Anderson Cancer Center, Houston (E.E.); Wroclaw Medical University, Wroclaw, Poland (K. Madziarska); Sygehus Lillebælt, Vejle, Denmark (B.N.); Pfizer, La Jolla (F.Z., X.L.), and Pfizer, San Francisco (K. Modelska) - both in California; and Astellas Pharma, Northbrook (J. Sugg, J. Steinberg), and the Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago (M.H.) - both in Illinois., Kolinsky MP; From the Englander Institute for Precision Medicine, Weill Cornell Medicine, New York (C.N.S.); the University of Paris Saclay, Villejuif, France (K.F.); the University of Montreal Hospital Center, Montreal (F.S.), and Cross Cancer Institute, University of Alberta, Edmonton (M.P.K.) - both in Canada; the Carolina Urologic Research Center, Myrtle Beach, SC (N.D.S.); Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy (U.D.); Vanderbilt University, Nashville (D.F.P.); the State University of Campinas (Unicamp), Campinas (U.F.), and the ABC Foundation School of Medicine, Santo André (D.I.G.C.) - both in Brazil; M.D. Anderson Cancer Center, Houston (E.E.); Wroclaw Medical University, Wroclaw, Poland (K. Madziarska); Sygehus Lillebælt, Vejle, Denmark (B.N.); Pfizer, La Jolla (F.Z., X.L.), and Pfizer, San Francisco (K. Modelska) - both in California; and Astellas Pharma, Northbrook (J. Sugg, J. Steinberg), and the Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago (M.H.) - both in Illinois., Cubero DIG; From the Englander Institute for Precision Medicine, Weill Cornell Medicine, New York (C.N.S.); the University of Paris Saclay, Villejuif, France (K.F.); the University of Montreal Hospital Center, Montreal (F.S.), and Cross Cancer Institute, University of Alberta, Edmonton (M.P.K.) - both in Canada; the Carolina Urologic Research Center, Myrtle Beach, SC (N.D.S.); Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy (U.D.); Vanderbilt University, Nashville (D.F.P.); the State University of Campinas (Unicamp), Campinas (U.F.), and the ABC Foundation School of Medicine, Santo André (D.I.G.C.) - both in Brazil; M.D. Anderson Cancer Center, Houston (E.E.); Wroclaw Medical University, Wroclaw, Poland (K. Madziarska); Sygehus Lillebælt, Vejle, Denmark (B.N.); Pfizer, La Jolla (F.Z., X.L.), and Pfizer, San Francisco (K. Modelska) - both in California; and Astellas Pharma, Northbrook (J. Sugg, J. Steinberg), and the Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago (M.H.) - both in Illinois., Noerby B; From the Englander Institute for Precision Medicine, Weill Cornell Medicine, New York (C.N.S.); the University of Paris Saclay, Villejuif, France (K.F.); the University of Montreal Hospital Center, Montreal (F.S.), and Cross Cancer Institute, University of Alberta, Edmonton (M.P.K.) - both in Canada; the Carolina Urologic Research Center, Myrtle Beach, SC (N.D.S.); Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy (U.D.); Vanderbilt University, Nashville (D.F.P.); the State University of Campinas (Unicamp), Campinas (U.F.), and the ABC Foundation School of Medicine, Santo André (D.I.G.C.) - both in Brazil; M.D. Anderson Cancer Center, Houston (E.E.); Wroclaw Medical University, Wroclaw, Poland (K. Madziarska); Sygehus Lillebælt, Vejle, Denmark (B.N.); Pfizer, La Jolla (F.Z., X.L.), and Pfizer, San Francisco (K. Modelska) - both in California; and Astellas Pharma, Northbrook (J. Sugg, J. Steinberg), and the Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago (M.H.) - both in Illinois., Zohren F; From the Englander Institute for Precision Medicine, Weill Cornell Medicine, New York (C.N.S.); the University of Paris Saclay, Villejuif, France (K.F.); the University of Montreal Hospital Center, Montreal (F.S.), and Cross Cancer Institute, University of Alberta, Edmonton (M.P.K.) - both in Canada; the Carolina Urologic Research Center, Myrtle Beach, SC (N.D.S.); Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy (U.D.); Vanderbilt University, Nashville (D.F.P.); the State University of Campinas (Unicamp), Campinas (U.F.), and the ABC Foundation School of Medicine, Santo André (D.I.G.C.) - both in Brazil; M.D. Anderson Cancer Center, Houston (E.E.); Wroclaw Medical University, Wroclaw, Poland (K. Madziarska); Sygehus Lillebælt, Vejle, Denmark (B.N.); Pfizer, La Jolla (F.Z., X.L.), and Pfizer, San Francisco (K. Modelska) - both in California; and Astellas Pharma, Northbrook (J. Sugg, J. Steinberg), and the Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago (M.H.) - both in Illinois., Lin X; From the Englander Institute for Precision Medicine, Weill Cornell Medicine, New York (C.N.S.); the University of Paris Saclay, Villejuif, France (K.F.); the University of Montreal Hospital Center, Montreal (F.S.), and Cross Cancer Institute, University of Alberta, Edmonton (M.P.K.) - both in Canada; the Carolina Urologic Research Center, Myrtle Beach, SC (N.D.S.); Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy (U.D.); Vanderbilt University, Nashville (D.F.P.); the State University of Campinas (Unicamp), Campinas (U.F.), and the ABC Foundation School of Medicine, Santo André (D.I.G.C.) - both in Brazil; M.D. Anderson Cancer Center, Houston (E.E.); Wroclaw Medical University, Wroclaw, Poland (K. Madziarska); Sygehus Lillebælt, Vejle, Denmark (B.N.); Pfizer, La Jolla (F.Z., X.L.), and Pfizer, San Francisco (K. Modelska) - both in California; and Astellas Pharma, Northbrook (J. Sugg, J. Steinberg), and the Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago (M.H.) - both in Illinois., Modelska K; From the Englander Institute for Precision Medicine, Weill Cornell Medicine, New York (C.N.S.); the University of Paris Saclay, Villejuif, France (K.F.); the University of Montreal Hospital Center, Montreal (F.S.), and Cross Cancer Institute, University of Alberta, Edmonton (M.P.K.) - both in Canada; the Carolina Urologic Research Center, Myrtle Beach, SC (N.D.S.); Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy (U.D.); Vanderbilt University, Nashville (D.F.P.); the State University of Campinas (Unicamp), Campinas (U.F.), and the ABC Foundation School of Medicine, Santo André (D.I.G.C.) - both in Brazil; M.D. Anderson Cancer Center, Houston (E.E.); Wroclaw Medical University, Wroclaw, Poland (K. Madziarska); Sygehus Lillebælt, Vejle, Denmark (B.N.); Pfizer, La Jolla (F.Z., X.L.), and Pfizer, San Francisco (K. Modelska) - both in California; and Astellas Pharma, Northbrook (J. Sugg, J. Steinberg), and the Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago (M.H.) - both in Illinois., Sugg J; From the Englander Institute for Precision Medicine, Weill Cornell Medicine, New York (C.N.S.); the University of Paris Saclay, Villejuif, France (K.F.); the University of Montreal Hospital Center, Montreal (F.S.), and Cross Cancer Institute, University of Alberta, Edmonton (M.P.K.) - both in Canada; the Carolina Urologic Research Center, Myrtle Beach, SC (N.D.S.); Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy (U.D.); Vanderbilt University, Nashville (D.F.P.); the State University of Campinas (Unicamp), Campinas (U.F.), and the ABC Foundation School of Medicine, Santo André (D.I.G.C.) - both in Brazil; M.D. Anderson Cancer Center, Houston (E.E.); Wroclaw Medical University, Wroclaw, Poland (K. Madziarska); Sygehus Lillebælt, Vejle, Denmark (B.N.); Pfizer, La Jolla (F.Z., X.L.), and Pfizer, San Francisco (K. Modelska) - both in California; and Astellas Pharma, Northbrook (J. Sugg, J. Steinberg), and the Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago (M.H.) - both in Illinois., Steinberg J; From the Englander Institute for Precision Medicine, Weill Cornell Medicine, New York (C.N.S.); the University of Paris Saclay, Villejuif, France (K.F.); the University of Montreal Hospital Center, Montreal (F.S.), and Cross Cancer Institute, University of Alberta, Edmonton (M.P.K.) - both in Canada; the Carolina Urologic Research Center, Myrtle Beach, SC (N.D.S.); Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy (U.D.); Vanderbilt University, Nashville (D.F.P.); the State University of Campinas (Unicamp), Campinas (U.F.), and the ABC Foundation School of Medicine, Santo André (D.I.G.C.) - both in Brazil; M.D. Anderson Cancer Center, Houston (E.E.); Wroclaw Medical University, Wroclaw, Poland (K. Madziarska); Sygehus Lillebælt, Vejle, Denmark (B.N.); Pfizer, La Jolla (F.Z., X.L.), and Pfizer, San Francisco (K. Modelska) - both in California; and Astellas Pharma, Northbrook (J. Sugg, J. Steinberg), and the Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago (M.H.) - both in Illinois., Hussain M; From the Englander Institute for Precision Medicine, Weill Cornell Medicine, New York (C.N.S.); the University of Paris Saclay, Villejuif, France (K.F.); the University of Montreal Hospital Center, Montreal (F.S.), and Cross Cancer Institute, University of Alberta, Edmonton (M.P.K.) - both in Canada; the Carolina Urologic Research Center, Myrtle Beach, SC (N.D.S.); Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy (U.D.); Vanderbilt University, Nashville (D.F.P.); the State University of Campinas (Unicamp), Campinas (U.F.), and the ABC Foundation School of Medicine, Santo André (D.I.G.C.) - both in Brazil; M.D. Anderson Cancer Center, Houston (E.E.); Wroclaw Medical University, Wroclaw, Poland (K. Madziarska); Sygehus Lillebælt, Vejle, Denmark (B.N.); Pfizer, La Jolla (F.Z., X.L.), and Pfizer, San Francisco (K. Modelska) - both in California; and Astellas Pharma, Northbrook (J. Sugg, J. Steinberg), and the Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago (M.H.) - both in Illinois.
Publikováno v:
The New England journal of medicine [N Engl J Med] 2020 Jun 04; Vol. 382 (23), pp. 2197-2206. Date of Electronic Publication: 2020 May 29.